• Black Iron and subsidiary of Glencore plc sign MOU to finance construction of Shymanivske Iron Ore Deposit
• Excellent infrastructure, with paved road to site, confirmed power and rail and port capacity, allows for a relatively low cost and phased build
• Project is expected to produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost
• Black Iron’s iron pellet feed product is expected to sell for a significantly higher price than benchmark iron ore

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron ore exploration and development company, is optimistic that construction could begin at its ultra-high-grade Shymanivske Iron Ore Project in Ukraine toward the end of the year. In an upbeat discussion with NNW’s Stuart Smith last month, CEO Matt Simpson, P.Eng., reminded stakeholders of the great strides that Black Iron made in 2018 and the huge leaps that the company is making this year (http://ibn.fm/MMAPI).

“We had some major milestones … with our real focus on relaunching the company,” Simpson said in the NNW interview, adding that Black Iron is looking at an ideal construction start date by the end of 2019. Discussions to secure the surface rights for the project are “well advanced,” he added.

One of the biggest milestones came in the form of a signed memorandum of understanding for the purpose of securing funds for construction of the Shymanivske Iron Ore Project with a subsidiary of commodities giant Glencore plc (OTC: GLCNF) (OTC: GLNCY). The non-binding MOU contemplates Glencore making an investment to help fund construction in exchange for securing the offtake of up to the full phase one planned annual production of four million tons, with terms and amount still to be negotiated (http://ibn.fm/foEdf).

“I am excited to welcome Glencore as an offtake investor for construction of the Shymanivske Project as well as their agreement to work with us to help secure additional financing,” Simpson said in a news release. “Glencore’s involvement significantly strengthens our capability and draws on their extensive international network, experience and market knowledge.”

Black Iron’s Shymanivske iron ore deposit is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added offering to customers, since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced (http://ibn.fm/nZ1XO).

Black Iron’s Shymanivske iron ore deposit is a true turnaround investment, Simpson said in his interview with NNW’s Smith.

“One thing that’s really unique and rare with this project … is that it’s almost agnostic to whatever the commodity price of iron ore is,” Simpson stated. “It’s very, very rare that you find a project, even in the 10-year downside pricing scenario, that still provides an after-tax rate of return in excess of 20 percent … we’re sitting on almost 70 percent after-tax return on this project at today’s iron ore prices. So very, very robust economics.”

For more information, visit the company’s website at www.BlackIron.com

The technical and scientific contents of this article have been reviewed and approved by Matt Simpson, P.Eng., CEO of Black Iron, who is a Qualified Person as defined by NI 43-101.

• Pursuing dual listing of common shares on the Canadian Securities Exchange
• Engaged a full-service law firm and consultant to manage compliance
• Lots of opportunity in 2019 with increased product lines, increased distribution and new partnerships

Earth Science Tech Inc. (OTCQB: ETST), an innovative biotech company based in Florida, is actively pursuing a dual listing of its common shares on the Canadian Securities Exchange (“CSE”). In December 2018, ETST engaged the counsel of Fasken, a full-service law firm with offices in Canada and worldwide, to assist with the process, including preparing and filing the required documentation (http://ibn.fm/Ui1o2).

In addition, ETST has engaged consultant Derek Lindsay to manage compliance while the company moves toward dual listing (http://ibn.fm/yTlbe). Along with managing compliance, Lindsay will be tasked with implementing an investor relations program and improving communications with investors.

“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” Lindsay, who has solid experience in accelerating the growth of both private and public companies, stated in a news release. Lindsay has served in various capacities and is well-versed in capital raising, strategic advising, investor relations and risk management.

Actively working toward dual listing is not halting the company’s continued work in the CBD, nutraceutical and pharmaceutical fields; nor is it slowing its advancement of medical devices or research and development activities. Preparations are in place for the launch of three new CBD products. The first commercial batch of Hygee medical devices is nearing completion and will be launched in Vietnam, which will act as a proving ground for the introduction of the device into other countries (http://ibn.fm/bAg6i).

Already distributing products to 40 countries, ETST recently expanded its sales reach into Mexico and South America through a distribution partnership agreement with Forzagen (http://ibn.fm/57cke). In addition to global distribution expansion, the company is increasing its markets in the United States. Thanks to a recent agreement with CannaBiz and Desert Sun Distribution, ETST’s CBD product line will soon be available to chiropractors, dispensaries, pharmacies, health care practitioners, athletic clubs and clinics.

In a news release (http://ibn.fm/B91JM), ETST Chairman Nickolas S. Tabraue said, “We have a lot of opportunity on deck for 2019, and we look forward to sharing the results of our strategies, which include our Latin American distribution partnership and upcoming High Grade Full Spectrum Iq2 Cannabinoids shot.”

For more information, visit the company’s website at www.EarthScienceTech.com

• The cannabis sector is set for exponential growth in the years to come, which has driven numerous companies to initiate large-scale production; the scope, however, is far less important than the cost-efficiency of the process
• Companies like Green Hygienics Holdings have competitive advantage due to proprietary high-tech cultivation technologies; these maximize yield and reduce the cost per unit
• Because of its investment in innovative cultivation methods, Green Hygienics has established an excellent position within the premium cannabis market

As the regulatory framework has changed dramatically over the past few years, the number of companies entering the cannabis sector has increased exponentially. In 2017 alone, there were 28,000 companies active in the field in the United States (http://ibn.fm/o0Jyf). Growth continued throughout 2018, when the legal marijuana industry reached $10.4 billion and created over a quarter of a million jobs (http://ibn.fm/VsXVb).

Large-scale U.S. and Canadian producers are building massive greenhouses and cultivation facilities to position themselves favorably in anticipation of future industry growth. Large-scale production is already driving prices down in the states that lack license limitations. As a result, experts have concluded that cost-efficient cannabis cultivation will be the primary driver for success, rather than the scope of facilities (http://ibn.fm/tTfaR).

As large producers bring the cost of cannabis down, companies that have a high yield and a low production price will be the ones that will rise to the surface. Sustainable, high yield production is heavily dependent on cultivation method and the utilization of the right technology.

Green Hygienics Holdings Inc. (OTCQB: GRYN) is already capitalizing on its proprietary cultivation technique. New developments have turned the company into a science-driven cultivation leader as it employs aeroponics-based techniques.

Aeroponics-based cultivation has nutrients delivered directly to the exposed roots of the cannabis plant. The root does not touch soil, rocks or a growth medium, which enhances control over every aspect of cannabis cultivation. This method significantly increases growing efficiency, with the cost per unit being brought down to less than one dollar. In comparison, indoor cultivation competitors have a cost per unit in the range of two to four dollars.

Green Hygienics Holdings also aims to obtain a better quality cannabis plant, enabling the company to establish itself as a leader on the premium market. The company targets the high-end medical and recreational cannabis markets through the creation of first-rate products and distinctive brands.

Finally, aeroponics allows for the conservation of resources – a factor that establishes the company’s green image and contributes to the reduction of production costs. Aeroponical cannabis cultivation preserves approximately 90-95 percent of the water that would be required in traditional production settings.

On top of relying on its proprietary cultivation method, Green Hygienics also focuses on quality control equipment that improves its market position even further. Green Hygienics employs commercial cultivation equipment and software solutions that enable constant monitoring of product growth and an immediate intervention in the event of a problem.

Green Hygienics Holdings is a full-scope premium cannabis cultivation company with headquarters in Las Vegas, Nevada. The company is establishing its operations in San Diego to benefit from the lucrative, $5-billion California cannabis market.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

• Cannabis industry job postings rose 445 percent in 2017
• Cannabis Strategic Ventures poised to meet this growing demand through multiple diverse subsidiaries
• PureOrganix, one such subsidiary, offers top-quality products that meet strict health and safety specifications

Cannabis Strategic Ventures Inc. (OTC: NUGS), a company focused on supporting entrepreneurial growth in the legal cannabis sector, offers personnel solutions to equip cannabis industry purveyors with the staffing resources that they need to achieve continued growth. Serving all vertical layers of the cannabis industry, Cannabis Strategic Ventures customizes its staffing services to each company’s individual needs, servicing cultivators, manufacturers, dispensaries and others in the cannabis marketplace.

The company aims to garner a corner of the $10 billion cannabis and $900 million hemp industries. In its approach, Cannabis Strategic Ventures has cultivated a diverse brand portfolio to broaden its industry reach.

One of its major subsidiaries, Pure Applied Sciences Inc., has cultivated a rich portfolio of ultra-high quality products. Its main brand is PureOrganix, a line of organic and pure cannabis oils and related accessories. The brand is responsible for noteworthy products like a “redefined” vape pen made from environmentally friendly materials, which features 400 percent more battery power than similar offerings from competitors. All PureOrganix products, also including batteries and apparel, conform to the most stringent current good manufacturing practices (“cGMP”) and meet FDA guidelines for active pharmaceuticals ingredients (“API”), an achievement that most small companies find extremely difficult to attain.

Additionally, another of the company’s subsidiaries, BudHire, is an outsourced employment service which uses a proven recruiting formula to help clients find the strongest candidates for positions within the cannabis industry. Through BudHire, Cannabis Strategic offers a variety of services to professionals, including temporary, seasonal and permanent staffing solutions, as well as human resources consulting.

Subsidiary Worldwide Staffing Group operates within the company as an independent wholly owned subsidiary. Its purpose is to provide non-cannabis-related employment and staffing services. As Worldwide continues to develop its operations into more vertical sectors of the cannabis industry, Cannabis Strategic plans to utilize the subsidiary’s aptitude and experience to move further into the cannabis staffing arena, focusing specifically on California’s markets.

As the cannabis industry continues to thrive, Cannabis Strategic has seen a dramatic increase in companies’ need for increased outsourced staffing. Specifically, cannabis industry job postings increased by 445 percent in 2017, a shocking increase from the prior year-over-year growth of 18 percent in 2016. The company feels well-positioned to meet this staffing demand through its diversified brands and strong industry presence.

For more information, visit the company’s website at www.CannabisStrategic.com

• An estimated 64 percent of American adults report drinking coffee on a regular basis, with the majority preparing coffee at home
• Youngevity International is focused on field-to-cup distribution in the coffee market through wholly owned subsidiary CLR Roasters
• Youngevity and CLR Roasters announced on March 6 that they plan to introduce two cannabidiol-infused coffee brands in May
• CBD-infused beverages are becoming a popular new market space, with the potential for between $900 million and $4.4 billion in revenues by 2024

Youngevity International Inc. (NASDAQ: YGYI) is cultivating a market that appeals to the more than 100 million Americans who drink coffee, as well as consumers in the burgeoning cannabis industries, thanks largely to a breakthrough in its efforts to infuse coffee with consistent dosing of hemp-derived cannabidiol (CBD) for wellness lifestyle interests.

Youngevity announced plans to launch two brands of cannabidiol-infused coffees on March 6, stating that sales are expected to begin in May. The HempFX brand is expected to roll out as a direct sales product through YGYI’s large sales network early in the month, followed by full-scale distribution by the end of the month. The company’s CLR Roasters subsidiary also anticipates a late-May rollout of its Javalution brand for retail store shelf distribution, and it has already begun retail sales presentations (http://ibn.fm/uq7ih).

“We have been perplexed in delivering CBD to a cup of coffee at consistent doses, but now we have a solution that passes the scrutiny of laboratory testing and we are excited to bring these products to market. Our team at Khrysos has cracked the code on the production of water-soluble CBDs,” Youngevity President and CFO Dave Briskie stated in a news release about the project.

Khrysos Global is a Florida-based manufacturer of hemp-based CBD extraction equipment that was acquired by Youngevity in February (http://ibn.fm/3pDY4). The deal included ownership of INX Labs and its testing facilities, which Briskie hailed as “a cornerstone” of the company’s developing CBD market strategy.

Both brands will be available in four profiles – Donut Shop, Dark Roast, House Blend and French Vanilla – according to the announcement. They will all come in a single-serve format that provides 10 milligrams of CBD per cup, and, since the company’s water-soluble CBD technology is deliverable in both powders and liquids, YGYI has a wide range for potential product development.

Youngevity is an omni-direct lifestyle company that gathers a virtual Main Street of products and services under one corporate entity with a hybrid direct sales business model that values e-commerce and social selling. Wholly owned subsidiary CLR Roasters produces gourmet coffees under its own boutique brands and manufactures a variety of private labels for major national chains, as well as Youngevity’s direct sales channel. The company remains one of North America’s largest suppliers to the cruise line industry.

CLR Roasters recently began filling a five-year contract to process and ship its first containers of green coffee, primarily comprised of high grown, washed Nicaraguan conventional coffees, as well as some naturals (http://ibn.fm/NaPPF). The company is also in the process of constructing one of Central America’s largest processing mills to expand its coffee plantation and processing operation in Nicaragua (http://ibn.fm/WWNWN) and increase its participation with its Nicaraguan-based partners from 50 percent to 75 percent of profits in the green coffee distribution business. The facility, when complete, is expected to house 28,000 square feet of office space and a 160,000-square-foot warehouse capable of holding 48 million pounds of green coffee with the ability to process over 53 million pounds of green coffee on an annual basis.

An estimated 64 percent of American adults drink coffee on a regular basis, according to a 2018 study with a sample of about 3,000 respondents commissioned by the National Coffee Association (“NCA”) (http://ibn.fm/TYemO). About 79 percent of those who reported drinking coffee said that they made it at home. Coffee is just the latest beverage market entry to anticipate CBD infusion, following on the heels of alcoholic drinks and sodas. Analysts at Deloitte foresee the potential revenues for the cannabis-infused beverages market at somewhere between $900 million and $4.4 billion by 2024, depending on the percentage of the cannabis products market that infusion captures (http://ibn.fm/HOT1X).

For more information, visit the company’s website at www.YGYI.com

• Marijuana Company of America receives patent for hempSMART Brain

Warren Buffett, ‘the Oracle of Omaha’, famously said, “A truly great business must have an enduring ‘moat’ that protects excellent returns on invested capital.” By a moat, the legendary investor meant some competitive advantage that would sustain the enterprise by protecting its market from rival firms. A patent, like the one issued to Marijuana Company of America Inc. (OTCQB: MCOA), can work just as well, he said (http://ibn.fm/qDB6Y).

A patent stops others from counterfeiting products or manufacturing replicas and knockoffs. It is particularly essential when the stakes are high, as they are in the U.S. hemp-based product market, which is forecast to approach $2 billion in three years. So the recent award of a U.S. patent puts MCOA in a decidedly stronger market position. The U.S. Patent and Trademark Office has granted MCOA a patent for the formulation of its flagship CBD product, hempSMART Brain, a wellness product formulated with a proprietary composition of natural ingredients and cannabidiol (CBD) for the enhancement of brain function (http://ibn.fm/90pwL).

MCOA’s hempSMART Brain is a unique product in that it utilizes a synergistic blend of natural neuroprotective and neuro-regenerative compounds, including CBD, in clinically researched and verified therapeutic amounts. Clinical studies indicate that CBD facilitates brain recovery by aiding in normal cell production. The human brain is “fitted” with natural specialized receptors for CBD, part of the endocannabinoid system that maintains homeostasis, or a stable internal environment in the body, as the external environment changes. Spurred by changes in the legislative environment, research into the use of cannabinoids to supplement neurologic and neurodegenerative concerns has been increasing, with encouraging results.

MCOA is an industrial hemp company that conducts and participates in product research and the development of legal hemp-based consumer products under the brand name ‘hempSMART’. The company distributes and sells its products through an affiliate marketing program. It intends to continue expanding its footprint in ancillary areas of the legalized cannabis and hemp industry.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

• High-speed 5G networks and enabled products are expected to begin rolling out this year, building momentum in coming years
• Spectrum Global Solutions provides end-to-end network services for telecommunication giants in the 5G space
• SGSI merger with WaveTech Global in the works, boosting companies’ responsiveness and enterprise value with uplisting application expected

Although it seems like 2019 has only just begun, some communications companies are already thinking about the year-end holidays as 5G-enabled wireless technologies prepare to storm the marketplace, with a likely inescapable presence in consumer advertising circles. That’s because some industry insiders, such as Qualcomm President Cristiano Amon, predict that consumers may not even have the option of buying a new high-end device without going all-in for the super-fast network come Christmas (http://ibn.fm/Zdbig).

End-to-end telecommunications network service provider Spectrum Global Solutions Inc. (OTCQB: SGSI) is positioned to enable the buildup of 5G networks as providers — including some major SGSI clients such as multinational telecommunications giants Sprint, AT&T and Verizon — rollout their options for service that’s expected to be 10- to 100-times faster than current coverage. SGSI’s subsidiaries, AW Solutions, ADEX Corp., TNS Inc. and Tropical Communications, serve the company’s array of carrier, aggregator, utility, enterprise, project management organization (“PMO”) and original equipment manufacturer (“OEM”) clients across the United States, Canada, Puerto Rico, Guam and the Caribbean.

Although the first mobile devices to pack a 5G punch won’t have many places to connect to the fast networks – and those that do face a marketplace response still wondering what to do with the faster speeds (http://ibn.fm/rBwOS) – Amon anticipates that “all carriers will have 5G” in the United States by the second half of 2019, and 4G will begin to fade away as its offspring begins to come into its own by late 2020 and the following year.

Spectrum Global Solutions Inc.’s services and software solutions are expected to receive an upgrade of their own following a definitive merger agreement with WaveTech Global Inc. – a next-generation technology platform that specializes in mobile network microservices, critical power management, asset lifecycle extension, data analytics and intellectual property development. Upon completion of the merger, SGSI will rebrand itself under the ‘WaveTech Global’ name and make applicable filings with regulatory officials as it also seeks uplisting to a Nasdaq exchange under ticker symbol ‘WAVE’, according to a news release about the agreement last month (http://ibn.fm/gfhpL).

Under the agreement, an investment of about $1.1 million from WaveTech Global allowed SGSI to clear a debt owed to Libertas Funding LLC in relation to the TNS acquisition, saving the company “thousands of dollars and (freeing) up additional cash that was being used for amortization payments,” according to SGSI CEO Roger Ponder (http://ibn.fm/17vAf).

The combined companies are expected to have an enterprise value of $130 million.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

• In a wide-ranging interview on MoneyTV, Warren Wang discussed long-term goals of CIIX, including an acquisition target
• Wang sees possibility of CIIX reaching $6 to $10 million in annual volume and uplisting to the NYSE or Nasdaq
• Wang previously announced plans to spin off wholly owned subsidiary CBD Biotech with a possible Nasdaq IPO

In an interview on MoneyTV with Donald Baillargeon, ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang noted his intention, within three to five years, for the company to uplist to the New York Stock Exchange or Nasdaq Small Cap Market as it reaches up to $10 million in annual volume (http://ibn.fm/VUk14).

“I’m pretty confident that we will see profitability and revenue growth in the next three to five years,” Wang said in the interview. “Our other goal is uplisting to the New York Stock Exchange (NYSE) or to Nasdaq because we are looking at an acquisition, and we are looking for revenue of $6 to $10 million in the next three to five years. I think we will definitely qualify for NYSE or Nasdaq on the small cap side.”

A diverse company with its U.S. base located in San Gabriel, California, CIIX has built an impressive international Chinese-speaking audience for its educational programs on investing and also for its industrial, hemp-infused consumer product line. The company recently announced that it plans to spin off its wholly owned subsidiary, CBD Biotech, with a possible Nasdaq IPO. Timing would be late in FY2019 or early the following year, Wang said (http://ibn.fm/NovlI).

To that end, CIIX has moved to rebrand and unify its ChineseHempOil.com consumer product line under the new ‘opt’ brand. The move consolidates CIIX’s domestic industrial hemp-infused consumer products and features two lines: opt Hemp and opt2mist (http://ibn.fm/JDmNN).

For more information, visit the company’s website at www.ChineseInvestors.com

• Cannabis Strategic Ventures focuses on building category leaders within the cannabis and CBD space
• It has varied subsidiaries that advance its goal of molding the future of the cannabis marketplace
• The company recently obtained a $3 million investment for business and operations expansion

Cannabis Strategic Ventures Inc. (OTC: NUGS) concentrates on supporting entrepreneurial growth within the emerging legal cannabis sector. It acquires, incubates, develops and partners with brands on a global scale to build category leaders within the cannabis and CBD (cannabidiol) space. The company has a portfolio of subsidiaries that comprise The Asher House Wellness, Budhire, Fitamins, LYXR, Halo Filters and Pure Applied Sciences Inc. Cannabis Strategic Ventures is headquartered in Los Angeles, California.

The company offers outsourced personnel solutions custom-made to match the growth potential of cannabis cultivators, manufacturers, dispensaries and other participants in the cannabis market. Furthermore, Cannabis Strategic Ventures engages in investment opportunities in the real estate, cultivation, extraction, distribution, packaging, dispensary operations and branded products areas within the cannabis arena.

Cannabis Strategic Ventures acquired Worldwide Staffing Group Inc. in 2018. Worldwide operates within the company as an independent wholly owned subsidiary. Worldwide provides strictly non-cannabis-related employment and staffing services. Its operational emphasis includes general clerical and administrative roles, marketing, accounting and other verticals.

Moreover, the company’s BudHire subsidiary is an outsourced employment service. BudHire aims to meet the needs of cannabis-related business operations. Through BudHire, Cannabis Strategic Ventures offers temporary, seasonal and permanent staffing solutions, as well as professional employment organization services and human resources consulting, to the cannabis industry (http://ibn.fm/vYDRw).

Subsidiary Pure Applied Sciences features a portfolio of ultra-high quality products. It does so through its Pure Organix brand. This brand consists of a line of organic and pure cannabis oils and related accessories. In essence, via its diverse subsidiaries, Cannabis Strategic Ventures works to provide access to safe and high-performing cannabis products (http://ibn.fm/Pb3Y5).

The cannabis market is forecast to generate $146 billion in revenues by 2025. Cultivation facilities are key to industry growth, as they provide the raw materials essential for cannabis commerce. Cannabis Strategic Ventures is positioning itself to leverage this growth opportunity via plans to establish a multi-acre cultivation facility in California to meet cannabis market demands (http://ibn.fm/xSEwk).

Recently, Cannabis Strategic Ventures announced that it had secured a $3 million investment to fast-track corporate expansion. The company obtained this investment from Triton Funds subsequent to a forthcoming S1 registration statement (http://ibn.fm/26iXX). This financing will enable Cannabis Strategic Ventures to hasten its business priorities associated with cannabis cultivation operations in California and the expansion of existing portfolio brands. San Diego, California-based Triton Funds is an investment fund centered on creating a greater sense of community by way of investments in local companies, entrepreneurs and philanthropy.

In a news release, Simon Yu, Cannabis Strategic Ventures’ chief executive officer, said, “Cannabis Strategic Ventures is proud to partner with Triton Funds, an organization with a mission that is closely aligned with ours, and who sees the potential of the larger cannabis industry. California is instrumental in setting the pace for the larger cannabis industry-both nationally and globally, and we are thrilled to have found a local partner to escalate the projects that we believe will positively impact stakeholder value to create superior, sustainable returns.”

With a vision to shape the cannabis industry’s future, Cannabis Strategic Ventures focuses on its portfolio of brands that are category leaders. The company continues to advance initiatives that facilitate the constant development of products, process and people. For investors, Cannabis Strategic Ventures offers the opportunity for ROI in the burgeoning cannabis space.

For more information, visit the company’s website at www.CannabisStrategic.com

• MustGrow Biologics is developing and commercializing a patented natural biopesticide
• The company’s solution uses the mustard seed’s natural defense mechanisms to protect plants
• MustGrow’s CEO recently talked about the major opportunity in organic pesticides and fertilizers

An agricultural biotechnology company, MustGrow Biologics focuses on innovative crop protection. The company is developing and commercializing its patented natural biopesticide and is targeting the fruit and vegetable and cannabis industries. Its natural biopesticide acts as a nematicide (chemicals used to kill nematodes, or tiny, parasitic worms), a fungicide, an insecticide and a fertilizer (http://ibn.fm/pGWcy). Its technologies deliver first-rate pest and pathogen control in combination with plant growth and yield benefits available across a wide array of crops. MustGrow Biologics is based in Saskatoon, Saskatchewan.

The company’s biopesticide has a U.S. EPA (Environmental Protection Agency) and Canadian PMRA (Pest Management Regulatory Agency) label and is an approved organic solution. This solution utilizes the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. In a research report, the New Brunswick Department of Agriculture, Aquaculture and Fisheries (http://ibn.fm/wsJj4) states, “When managed properly mustard offers another tool to help growers control soil born pests and diseases. The use of mustard as a biofumigant is particularly interesting for organic producers… Although mustard is a remarkable biofumigant, it has similar benefits that is expected from any other cover crop such as; prevention of soil erosion, recycling of soil nutrients, improved soil structure and maintaining soil organic matter.”

Recently, MustGrow Biologics President and Chief Executive Officer Corey Giasson commented on the significant opportunity in biopesticides and fertilizers. The company is advancing its pesticide and fertilizer labels using the Health Canada-defined “Purposes” as a foundation. These are in place to see (http://ibn.fm/TISnH) that “The requirements of the Pest Control Products Act and the Cannabis Act related to the use of pest control products (PCPs) are met.” MustGrow Biologics is working with Health Canada to develop a family of approved biopesticides and fertilizers to ensure that Canadian cannabis license-holders are using science-based products to grow cannabis.

Giasson recently noted that the company is well-positioned to deliver a compliant cannabis label via tailoring of its EPA- and PMRA-approved pesticide. In a news release (http://ibn.fm/F3pXS), he talked about the mega-markets outside of cannabis, stating, “Several alarming articles involving dangerous pesticide-use have recently been brought to my attention. Many of these concerns are from the agricultural community and chemicals industry itself – they are looking to MustGrow to advance and provide a safe and natural solution.”

MustGrow Biologics’ EPA- and PRMA-approved offerings and all of the third-party solutions on its radar are natural products. The company does not work with organophosphates, which are broadly-used and extremely dangerous chemical pesticides. Regarding cannabis, MustGrow is now developing a reliable, safe and biodegradable solution that follows Health Canada regulations. The positioning of the company’s product is as an effective pre-plant soil treatment. This lessens the chance for any non-treated soil to contaminate greenhouses with soil born pests or diseases.

MustGrow Biologics continues to focus on inventive solutions that have extensive applications within agriculture. To date, the company has completed more than 110 independent third-party field trials. MustGrow is at the forefront of development of unique solutions to help fruit and vegetable growers and cannabis growers control pests and crop diseases.

For more information, visit the company’s website at www.MustGrow.ca